Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01695603
Other study ID # Intellibrain
Secondary ID
Status Completed
Phase N/A
First received September 20, 2012
Last updated May 3, 2017
Start date March 2012
Est. completion date March 2017

Study information

Verified date May 2017
Source University of Lausanne Hospitals
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Comparison of the ability of a new automated ventilatory mode named Intellibrain to maintain capnia and oxgen partial pressure within predefined ranges in comparison to the control of capnia and oxgen partial pressure obtained by using standard controlled ventilation modes in brain injured patients. Comparison of the numbers of alarms and required settings modifications observed with each ventilatory mode.


Recruitment information / eligibility

Status Completed
Enrollment 23
Est. completion date March 2017
Est. primary completion date March 2017
Accepts healthy volunteers No
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria:

- Brain injury ( traumatic brain injury, subarachnoi8dal haemorrhage, intracerebral hemorrhage, ischemic stroke)

- Glasgow coma scale of 9 or less

- Controlled mechanical ventilation required

- Intracranial pressure monitoring required for clinical reasons

Exclusion Criteria:

- age under 16 years old

- clinical signs of brainstem lesions

- patients with withdrawal order or for whom organ donation is under discussion

- major haemodynamic instability

- High carbon dioxide alveoloarterial gradient (>10 mmHg) and/or suffering of severe hypoxemia (PaO2/FIO2 < 150 mmHg)

- Patients included in another interventional clinical study

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Intellivent


Locations

Country Name City State
Switzerland Adult Intensive Care and Burn Unit, University hospital of Lausanne Lausanne

Sponsors (2)

Lead Sponsor Collaborator
Prof. Philippe Jolliet University of Lausanne Hospitals

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Partial pressure of carbon dioxide The partial pressure of carbon dioxide (PaCO2) will be recorded every thirty minutes during 2 hours under standard controlled ventilation and during 2 hours under Intellivent ventilation
Secondary Partial pressure of oxygen The partial pressure of oxygen (PaCO2) will be recorded every thirty minutes during 2 hours under standard controlled ventilation and during 2 hours under Intellivent ventilation
Secondary Number of alarms generated by the ventilator The number of alarms generated by the ventilator will be recorded during 2 hours under standard controlled ventilation and during 2 hours under Intellivent ventilation
Secondary Number of settings modifications The number of ventilator settings modifications required will be recorded during 2 hours under standard controlled ventilation and during 2 hours under Intellivent ventilation
Secondary Intracranial pressure Intracranial pressure will be recorded continuously during 2 hours under standard controlled ventilation and during 2 hours under Intellivent ventilation
Secondary Respiratory parameters Various respiratory parameters tidal volume, respiratory rate, minute ventilation, airway pressure) will be recorded during 2 hours under standard controlled ventilation and during 2 hours under Intellivent ventilation
Secondary Cerebral vasoreactivity Cerebral vasoreactivity will be studied from the intracranial pressure and invasive arterial pressure curves recorded during 2 hours under standard controlled ventilation and during 2 hours under Intellivent ventilation
Secondary Partial pressure of oxygen in the brain tissue if available Partial pressure of oxygen in the brain tissue, if available for clinical reasons, will be recorded during 2 hours under standard controlled ventilation and during 2 hours under Intellivent ventilation
Secondary Number of therapeutic actions needed to reduce intracranial pressure The number of therapeutic actions needed to reduce intracranial pressure will be recorded during two hours under standard controlled ventilation and during two hours under Intellivent ventilation.
Secondary Cerebral perfusion pressure Cerebral perfusion pressure will be recorded continuously during 2 hours under standard controlled ventilation and during 2 hours under Intellivent ventilation
See also
  Status Clinical Trial Phase
Completed NCT03223506 - Validation of a Physiological Based Pharmacokinetic Model by the Study of Paracetamol Distribution in the Brain Compartments in Brain Injured Patients Phase 1